| Ident. | Authors (with country if any) | Title |
|---|
| 000090 (2019) |
Jeffrey R. Curtis [États-Unis] ; Xavier Mariette [France] ; Cécile Gaujoux-Viala [France] ; Andrew Blauvelt [États-Unis] ; Tore K. Kvien [Norvège] ; William J. Sandborn [États-Unis] ; Kevin Winthrop [États-Unis] ; Marc De Longueville [Belgique] ; Ivo Huybrechts [Belgique] ; Vivian P. Bykerk [États-Unis] | Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials |
| 000095 (2019) |
Vincent Cottin [France] ; Kevin K. Brown [États-Unis] | Interstitial lung disease associated with systemic sclerosis (SSc-ILD) |
| 000097 (2019) |
Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France] | Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs |
| 000098 (2019) |
Yann Nguyen [France] ; Carine Salliot [France] ; Gaëlle Gusto [France] ; Elise Descamps [France] ; Xavier Mariette [France] ; Marie-Christine Boutron-Ruault [France] ; Raphaèle Seror [France] | Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study |
| 000103 (2019) |
Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France] | Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses |
| 000104 (2019) |
Ivan Foeldvari [Allemagne] ; Tamàs Constantin [Hongrie] ; Jelena Vojinovi [Serbie] ; Gerd Horneff [Allemagne] ; Vyacheslav Chasnyk [Russie] ; Joke Dehoorne [Belgique] ; Violeta Panaviene [Lituanie] ; Gordana Suši [Serbie] ; Valda Stanevicha [Lettonie] ; Katarzyna Kobusinska [Pologne] ; Zbigniew Zuber [Pologne] ; Bogna Dobrzyniecka [Pologne] ; Irina Nikishina [Russie] ; Brigitte Bader-Meunier [France] ; Luciana Breda [Italie] ; Pavla Doležalová [République tchèque] ; Chantal Job-Deslandre [France] ; Ingrida Rumba-Rozenfelde [Lettonie] ; Nico Wulffraat [Pays-Bas] ; Ronald D. Pedersen [États-Unis] ; Jack F. Bukowski [États-Unis] ; Bonnie Vlahos [États-Unis] ; Alberto Martini [Italie] ; Nicolino Ruperto [Italie] | Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial |
| 000105 (2019) |
Christien Rondaan [Pays-Bas] ; Victoria Furer [Israël] ; Marloes W. Heijstek [Pays-Bas] ; Nancy Agmon-Levin [Israël] ; Marc Bijl [Pays-Bas] ; Ferdinand C. Breedveld [Pays-Bas] ; Raffaele D Melio [Italie] ; Maxime Dougados [France] ; Meliha C. Kapetanovic [Suède] ; Jacob M. Van Laar [Pays-Bas] ; Annette Ladefoged De Thurah [Danemark] ; Robert Landewé [Pays-Bas] ; Anna Molto [France] ; Ulf Müller-Ladner [Allemagne] ; Karen Schreiber [Royaume-Uni, Danemark] ; Leo Smolar [Israël] ; Jim Walker ; Klaus Warnatz [Allemagne] ; Nico M. Wulffraat [Pays-Bas] ; Sander Van Assen [Pays-Bas] ; Ori Elkayam [Israël] | Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations |
| 000107 (2019) |
Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raimon Sanmarti [Espagne] ; Min Bao [États-Unis] ; Jenny Devenport [États-Unis] ; Attila Pethö-Schramm [Suisse] | Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis |
| 000110 (2019) |
Noemi Muszbek [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Marie Fournier [France] ; Chieh-I Chen [États-Unis] ; Andreas Kuznik [États-Unis] ; Zsofia Kiss [Royaume-Uni] ; Peter Gal [Hongrie] ; Kaleb Michaud [États-Unis] | Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs |
| 000112 (2019) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study |
| 000113 (2019) |
Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France] | Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis |
| 000116 (2019) |
Guillaume Morelle [France] ; Julie Gueudry [France] ; Florence Uettwiller [France] ; Carine Wouters [France] ; Brigitte Bader-Meunier [France] ; Mathieu P. Robert [France] ; Dominique Monnet [France] ; Bahram Bodaghi [France] ; Martine Grall-Lerosey [France] ; Pierre Quartier [France] | Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort |
| 000118 (2019) |
Benjamin Castagné [France] ; Marie Viprey [France] ; Julie Martin [France] ; Anne-Marie Schott [France] ; Michel Cucherat [France] ; Martin Soubrier [France] | Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis |
| 000120 (2019) |
Iain B. Mcinnes [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Maria-Antonietta D'Agostino [France] ; Manuela Le Bars [France] ; Subhashis Banerjee [États-Unis] ; Harris A. Ahmad [États-Unis] ; Yedid Elbez [France] ; Philip J. Mease [États-Unis] | Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial |
| 000121 (2019) |
Josette Biya ; Sandra Dury ; Jeanne-Marie Perotin [France] ; Claire Launois ; Maxime Dewolf ; Gaëtan Deslée [France] ; François Lebargy | Assessment of TNF-α inhibitors in airway involvement of relapsing polychondritis |
| 000123 (2019) |
Sebastiaan J. Vastert [Pays-Bas] ; Yvan Jamilloux [France] ; Pierre Quartier [France] ; Sven Ohlman [Suède] ; Lisa Osterling Koskinen [Suède] ; Torbjörn Kullenberg [Suède] ; Karin Franck-Larsson [Suède] ; Bruno Fautrel [France] ; Fabrizio De Benedetti [Italie] | Anakinra in children and adults with Still’s disease |
| 000124 (2019) |
François Vercruysse [France] ; Thomas Barnetche [France] ; Estibaliz Lazaro [France] ; Emilie Shipley [France] ; François Lifermann [France] ; Alexandre Balageas [France] ; Xavier Delbrel [France] ; Bruno Fautrel [France] ; Christophe Richez [France] ; Thierry Schaeverbeke [France] ; Marie-Elise Truchetet [France] | Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy |
| 000125 (2019) |
Amayelle Rey [France] ; Benjamin Batteux [France] ; Solène M. Laville [France] ; Justine Marienne [France] ; Kamel Masmoudi [France] ; Valérie Gras-Champel [France] ; Sophie Liabeuf [France] | Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study |
| 000145 (2018) |
Anaïs Huwart [France] ; Florent Garrigues [France] ; Sandrine Jousse-Joulin [France] ; Thierry Marhadour [France] ; Dewi Guellec [France] ; Divi Cornec [France] ; Maelenn Gouillou [France] ; Alain Saraux [France] ; Valérie Devauchelle-Pensec [France] | Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab |
| 000146 (2018) |
Elena García-Martínez [Espagne] ; Melody Smith [États-Unis] ; Aitziber Buqué [États-Unis] ; Fernando Aranda [Espagne] ; Francisco Ayala De La Pe A [Espagne] ; Alejandra Ivars [Espagne] ; Manuel Sanchez Cánovas [Espagne] ; Ma Angeles Vicente Conesa [Espagne] ; Jitka Fucikova [République tchèque] ; Radek Spisek [République tchèque] ; Laurence Zitvogel [France] ; Guido Kroemer [France, Suède] ; Lorenzo Galluzzi [États-Unis, France] | Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy |
| 000148 (2018) |
Sachiyo Oishi [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Chantal Job-Deslandre [France] ; Loic Guillevin [France] ; Jacques Benichou [France] ; René Marc Flipo [France] ; Carole Duquenne [France] ; Francis Guillemin [France] ; Alain Saraux [France] | Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort) |
